The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Hydrix (HYD) has implanted its first female patient in Singapore with its AngelMed Guardian device
  • This marks the fifth patient to successfully receive the implant in the country
  • The AngelMed Guardian uses machine learning algorithms and artificial intelligence to continuously monitor the patient’s heart signal
  • This then warns medical professionals of any coronary symptoms such, as silent heart attacks
  • Hydrix has ended the day 3.03 per cent in the green with shares trading for 34 cents each

Hydrix (HYD) has implanted its first female patient in Singapore with its AngelMed Guardian device.

The patient who received the implant has been discharged from hospital and is in good health.

This marks the fifth patient to successfully receive the AngelMed Guardian implant in Singapore.

Further, the implant was performed under the supervision of Cardiologist Dr Leslie Lam.

“With each procedure, awareness of the AngelMed Guardian technology grows. We look forward to more procedures being announced in the near future,” General Manager Paul Kelly said.

The AngelMed Guardian uses machine learning algorithms and artificial intelligence to continuously monitor the patient’s heart signal and warn of any coronary syndrome, such as silent heat attacks.

Hydrix has ended the day 3.03 per cent in the green with shares trading for 34 cents each in a $41.70 million market cap.

HYD by the numbers
More From The Market Online

Recce breathes better on positive lung infection drug pilot test results

Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327,…
The Market Online Video

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug…

Botanix isn’t sweating on FDA approval for Sofdra

Botanix has submitted the last label materials to the FDA seeking approval for Sofdra™ a prescription…

Singular Health launches upgraded DICOM viewer, with patient-friendly features for engagement with medical records

Singular Health Ltd has launched an upgraded version of its DICOM viewer, set to allow greater…